Does a breathlessness intervention service ('CBIS') reduce stress significantly more than usual care in breathless patients with advanced non-malignant disease and their carers? A phase II feasibility study

ISRCTN ISRCTN70836126
DOI https://doi.org/10.1186/ISRCTN70836126
Secondary identifying numbers 14073
Submission date
25/04/2013
Registration date
26/04/2013
Last edited
29/05/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Dr Richella Ryan
Scientific

Palliative Care Team
Addenbrookes Hospital
Hills Road
Cambridge
CB2 0QQ
United Kingdom

Email rcr41@medschl.cam.ac.uk

Study information

Study designRandomised interventional trial; Design type: Treatment
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleDoes a breathlessness intervention service ('CBIS') reduce stress significantly more than usual care in breathless patients with advanced non-malignant disease and their carers? A phase II feasibility study
Study acronymBISCORT
Study hypothesisBackground: Breathlessness is common in people with serious heart and lung disease. Experts agree that using a number of treatments together (e.g. exercise, relaxation, medication) brings the greatest improvement. The ‘Cambridge Breathlessness-Intervention Service (CBIS)’ uses this approach in patients and their carers. We think that 'CBIS' works by reducing stress. Stress levels in the body can be assessed by measuring the amount of a hormone called ‘cortisol’ in saliva.

Aim: We want to know whether CBIS reduces stress. We can only answer this question accurately by doing a large study. This is a small study testing our methods before doing the large study.

Methods: We plan to recruit 36 patients along with their carers. Half of the participants will receive 'CBIS' and half of them will not. We will measure salivary cortisol levels before and after study entry (at 0 and 8 weeks) in both the participants receiving the service and in those who do not receive the service. In addition, participants will be asked to complete questionnaires about their level of breathlessness and stress. We will also measure sleep and inflammation as these phenomena are related to chronic stress. At 8 weeks, we will compare the results between the two groups. Those who receive CBIS will have further measurements taken at 12 and 20 weeks to establish whether there is a long-term change in the measures. All participants will be invited to take part in an interview about their experience of the study at 20 weeks.

More details can be found at: http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=14073
Ethics approval(s)First MREC approval date 21/02/2013, ref: 13/EE/0021
ConditionTopic: Cardiovascular, Respiratory; Subtopic: Cardiovascular (all Subtopics), Respiratory (all Subtopics); Disease: Cardiovascular, Respiratory
InterventionCBIS, The ‘Cambridge Breathlessness Intervention Service’ (‘CBIS’) is a multidisciplinary service consisting of a medical consultant, an occupational therapist and a physiotherapist. It uses a psychologically-informed and rehabilitative approach to address the multi-dimensional nature of breathlessness. The intervention consists of multiple interacting components which are delivered in a flexible manner.
Intervention typeOther
Primary outcome measureDiurnal Salivary Coritsol Profile; Timepoints: For parallel study: week 0 and 8, For longitudinal study (intervention arm only): week 0, 8,12, 20
Secondary outcome measuresNot provided at time of registration
Overall study start date11/03/2013
Overall study end date31/01/2015

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsUK Sample Size: 72; Description: The sample will consist of 36 patient-carer dyads, resulting in a total of 72 participants.
Participant inclusion criteriaPatients:
Any patient referred to CBIS with non-malignant disease who:
1. Has a diagnosed and investigated cause for breathlessness
2. Is troubled by breathlessness despite optimal medical therapy
3. May benefit from a self-management programme
4. Has an ‘informal live-in’ carer

Carers:
1. Is an informal carer (i.e not employed or paid as a carer) of the referred patient
2. Lives with the referred patient
3. Has some involvement in the patient’s day-to-day activities or care
4. Male & Female; lower age limit 18 years, upper age limit 100 years
Participant exclusion criteriaPatients:
1. Active cancer
2. Rapidly progressing disease-course (CBIS cannot be delayed in this situation)
3. On corticosteroids at the time of screening or within the preceding month
4. Unable to provide informed consent
5. Has a baseline perceived stress scale (PSS) score of <12 (PSS is a scale for measuring subjective stress. The maximum score is 40 and a score of 12/40 is the average score for a normal population)
6. Does not fulfil the inclusion criteria

Carers:
1. On corticosteroids at the time of screening or within the preceding month
2. Suffers from breathlessness
3. Has a baseline PSS<12
4. Unable to provide informed consent
5. Works regular night shifts
6. Does not fulfil the inclusion criteria
Recruitment start date11/03/2013
Recruitment end date31/01/2015

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Palliative Care Team
Cambridge
CB2 0QQ
United Kingdom

Sponsor information

Cambridge University Hospitals NHS Foundation Trust (UK)
Hospital/treatment centre

Palliative Care Team
Addenbrookes Hospital
Hills Road
Cambridge
CB2 0QQ
England
United Kingdom

Website http://www.cuh.org.uk
ROR logo "ROR" https://ror.org/04v54gj93

Funders

Funder type

Government

NIHR (UK) - Doctoral Research Fellowship; Grant Codes: NIHR-DRF-2012-05-702

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No

Editorial Notes

29/05/2020: No publications found.
07/06/2019: Internal review.
03/06/2019: Contact details updated.
31/05/2019: Internal review.
06/01/2017: No publications found in PubMed, verifying study status with principal investigator.